Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Indivior ( (GB:INDV) ) is now available.
Indivior PLC announced the repurchase and cancellation of 209,246 of its ordinary shares through its $100 million Share Repurchase Program, executed by Morgan Stanley. This move, which aligns with regulatory requirements, reduces the total number of shares in circulation, potentially increasing the value of remaining shares and impacting shareholder equity calculations.
More about Indivior
Indivior PLC operates in the pharmaceutical industry, focusing on developing and marketing medications for the treatment of addiction and other mental health disorders.
YTD Price Performance: -18.31%
Average Trading Volume: 453,860
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.21B
Learn more about INDV stock on TipRanks’ Stock Analysis page.